CID 25151352

Pexidartinib

Structural Information

Molecular Formula
C20H15ClF3N5
SMILES
C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F
InChI
InChI=1S/C20H15ClF3N5/c21-15-6-16-14(10-28-19(16)29-11-15)5-12-2-4-18(26-7-12)27-9-13-1-3-17(25-8-13)20(22,23)24/h1-4,6-8,10-11H,5,9H2,(H,26,27)(H,28,29)
InChIKey
JGWRKYUXBBNENE-UHFFFAOYSA-N
Compound name
5-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-[[6-(trifluoromethyl)pyridin-3-yl]methyl]pyridin-2-amine
Related CIDs

2D Structure

compound 2d structure
7
Annotation Hits

218
References

4760
Patents

417.0968 Da
Monoisotopic Mass

4.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 418.10408 194.7
[M+Na]+ 440.08602 205.8
[M-H]- 416.08952 195.6
[M+NH4]+ 435.13062 202.2
[M+K]+ 456.05996 194.9
[M+H-H2O]+ 400.09406 180.7
[M+HCOO]- 462.09500 204.6
[M+CH3COO]- 476.11065 202.5
[M+Na-2H]- 438.07147 198.8
[M]+ 417.09625 194.0
[M]- 417.09735 194.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe